Clinical Trial Update: Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the combination of fenofibrate and simvastatin against pravastatin for hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Fenofibrate + Simvastatin (combination) (fenofibrate and simvastatin)
• Pravastatin (pravastatin)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED